Cassava Sciences Inc vs Ishares Msci Thailand Etf — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Ishares Msci Thailand Etf trades at $72.82. The key difference: Ishares Msci Thailand Etf is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | THD | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $4.64 | $75.05 |
52-Week Low | $1.09 | $53.83 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
The iShares MSCI Thailand ETF (THD) trades at $72.82, showing modest daily gains with a bullish technical signal from moving averages. Recent performance has been strong, delivering nearly 38% total returns over the past year, largely driven by exposure to AI hardware plays like Delta Electronics. The fund announced a $1.71 dividend for H1-2026, with key dates in June.
Outlook remains cautiously optimistic given THD's recent outperformance within ASEAN markets, though concentration in AI-related holdings creates vulnerability to sector rotation. Key risks include Thailand's monetary policy uncertainty and regional economic sensitivity to global AI investment cycles.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →